Randomized, Double-Blind, Placebo-Controlled Study of Anti-Mycobacterial Therapy (RHB-104) in Active Crohn’s Disease

This study, conducted between 4 October 2013, and 30 November 2018, tested the hypothesis that triple antimicrobial therapy, targeting <i>Mycobacterium avium</i> subspecies <i>paratuberculosis</i> (MAP), long considered a putative cause, would favorably affect Crohn’s disease. A double-blind multice...

पूर्ण विवरण

ग्रंथसूची विवरण

मुख्य लेखकों:	David Y. Graham, Saleh A. Naser, Thomas Borody, Zbigniew Hebzda, Harry Sarles, Scott Levenson, Robert Hardi, Tomasz Arłukowicz, Petar Svorcan, Reza Fathi, Aida Bibliowicz, Patricia Anderson, Patrick McLean, Clara Fehrmann, M. Scott Harris, Shuhong Zhao, Ira N. Kalfus
स्वरूप:	Artigo
भाषा:	Inglês
प्रकाशित:	MDPI AG 2024-07-01
श्रृंखला:	Antibiotics
विषय:	RHB-104 Crohn’s disease <i>Mycobacterium avium</i> subspecies <i>paratuberculosis</i> clinical trial clarithromycin rifabutin
ऑनलाइन पहुंच:	https://www.mdpi.com/2079-6382/13/8/694
टैग:	टैग जोड़ें कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!